Jin Medical International Ltd. (NASDAQ:ZJYL – Get Free Report) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totaling 79,215 shares, a decrease of 63.6% from the December 15th total of 217,828 shares. Based on an average daily volume of 153,591 shares, the short-interest ratio is presently 0.5 days. Approximately 0.1% of the company’s stock are short sold. Approximately 0.1% of the company’s stock are short sold. Based on an average daily volume of 153,591 shares, the short-interest ratio is presently 0.5 days.
Analysts Set New Price Targets
Separately, Weiss Ratings upgraded Jin Medical International from a “sell (d)” rating to a “hold (c-)” rating in a research note on Monday, December 29th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of “Hold”.
Check Out Our Latest Stock Report on Jin Medical International
Jin Medical International Stock Performance
Jin Medical International Company Profile
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
Further Reading
- Five stocks we like better than Jin Medical International
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Ominous day” coming to stocks…
- Punch these codes into your ordinary brokerage account
- The Crash Has Already Started (Most Just Don’t See It Yet)
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Jin Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jin Medical International and related companies with MarketBeat.com's FREE daily email newsletter.
